Muscle Tension Dysphonia Treatment Market Size & Share, by Treatment Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Proton-pump Inhibitors, Analgesics, Antacids, Voice Therapy, Behavioural Counseling); Age Group (Pediatrics, Adults, Elderly); Distribution Channel (Hospitals, Clinics, Retails, Specialized Centers, Retail Pharmacies, Online Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5631
  • Published Date: Feb 12, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Muscle Tension Dysphonia Treatment Market size is anticipated to reach USD 20 Billion by the end of 2036, growing at a CAGR of 3% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of muscle tension dysphonia treatment was over USD 13 Billion. The market for muscle tension dysphonia is growing as vocal issues become more common. The market for muscular tension dysphonia treatment offers a range of diagnostic procedures, including laryngoscopy and stroboscopy, evaluation of speech-language pathology, and search for further abnormalities that may be related. As per a report in 2019, a third of cases of dysphonia were reported by workers in the service sector. According to estimates, those who work in the service sector have a 2.6-fold increased risk of benign laryngeal development. Voice issues were estimated to affect 46% of vocalists on average. Therefore, these factors are propelling the growth of the muscle tension dysphonia treatment market.

Anxiety and stress may be linked to muscle tension dysphonia. This frequently happens after contracting a cold flu, or other upper respiratory infection. Muscle tension dysphonia is frequently accompanied by a variety of symptoms, such as an uneven voice, difficulty singing, a broken or airy voice, vocal fatigue, a rough and hoarse voice, etc.


Muscle Tension Dysphonia Treatment Market
Get more information on this report: Request Free Sample PDF


Muscle Tension Dysphonia Treatment Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~ 3%

Base Year Market Size (2023)

 ~ USD 13 Billion

Forecast Year Market Size (2036)

 ~ USD 20 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Muscle Tension Dysphonia Treatment Market: Growth Drivers and Challenges

Market-Growth-Drivers

Growth Drivers

  • Growing Government Sponsored Research and Development Activities - There is an increased focus on research and development, which is expanding the muscle tension dysphonia treatment market. These prospects will help the market for therapies for muscular tension dysphonia. To encourage scientists and pharmaceutical companies to produce novel drugs, the government is funding research and development (R&D) initiatives. For instance, a leading provider of virtual speech therapy, Great Speech, is pleased to announce a strategic alliance with Bennie, a global platform for employee benefits that aims to increase benefit accessibility and comprehensibility. Bennie members can use the knowledge and resources of the Great Speech nationwide network of more than 200 licensed speech-language pathologists from the convenience of their homes with just an internet connection to solve communication difficulties.
  • Growing Demand for Personalized Diagnostic Techniques - The growing need for specialized and personalized diagnostic methods will also boost the expansion. There are no specific diagnostic techniques for this condition. Both the speech-language pathologist and the laryngologist base their diagnosis on the patient's description of their symptoms, the quality of their voice, and an inspection of their vocal folds during speech. Also, the growing number of retail pharmacies in economically developed nations and the use of several drugs for muscular tension dysphonia, which are provided through retail pharmacies, present opportunities for muscle tension dysphonia treatment market expansion. Because individuals may easily obtain their drugs from retail pharmacies, patients frequently prefer them.
  • Increased Stress among Adults and Children - The market for treatments for muscular tension dysphonia is anticipated to be driven by the increasing prevalence of voice abnormalities in both adults and children. The market for treatments for muscular tension dysphonia is mostly driven by rising stress. As per a report, in 2022, 25% of those 65 years of age and above reported having moderate to severe symptoms of stress, even though young people globally are more likely to report such symptoms. Furthermore, it is anticipated that the market for muscular tension dysphonia will grow due to an increase in chronic illnesses such as autism, Parkinson's disease, brain tumors, cerebral palsy, and stroke.

Challenges

  • Lack of Awareness among Individuals - One of the primary challenges is the general public's and healthcare professionals' inadequate knowledge and comprehension of the illness. This may result in a delayed or incorrect diagnosis, which would make it more difficult for the patient to get the right care. As a result, this aspect can hinder the muscle tension dysphonia treatment market growth for treatments for muscular tension dysphonia.
  • High Costs Related to the Treatment may Hamper the Growth of the Market
  • Limited Access to Voice Therapy Services in Some Areas may Impede the Market Growth


Muscle Tension Dysphonia Treatment Segmentation

Age Group (Pediatrics, Adults, Elderly)

The adults segment in the muscle tension dysphonia treatment market is poised to hold the largest share of 46% during the forecast period. The segment's expansion can be linked to the rise in adult cases of muscle tension dysphonia. Numerous causes, including overuse of the voice, stress, and incorrect vocal technique—all of which are more common in adults—can contribute to this illness. Adults may also seek treatment for muscular tension dysphonia to enhance their social or professional communication abilities. According to a report, in 2023 disabilities in communication affect about 10% of people worldwide. The desire for treatment options, such as voice therapy, is driving the expansion of the adult segment as knowledge of the issue rises and more adults realize how muscular tension dysphonia affects their day-to-day lives.

Treatment Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Proton-pump Inhibitors, Analgesics, Antacids, Voice Therapy, Behavioural Counseling)

The voice therapy segment in muscle tension dysphonia treatment market is anticipated to hold a share of 34% during the forecast period. The segment is expanding because it provides a successful and non-invasive method of treating the illness. The main goals of voice therapy are to promote healthy vocal habits, ease muscular tension, and enhance vocal technique. It gives people the skills and methods they need to take back control of their voice and reduce symptoms. Since voice therapy can significantly improve voice quality and lessen vocal strain, it is frequently advised as a first-line treatment for muscular tension dysphonia. The voice treatment services are expected to increase as more people become aware of the advantages of voice therapy and as more medical professionals become specialists in this field. Additionally, the efficacy of voice treatment strategies and approaches has improved due to technological and medical developments. Therefore, altogether these factors contribute to the growth of the voice therapy segment.

Our in-depth analysis of the global muscle tension dysphonia treatment market includes the following segments:

          Treatment Type

  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Proton-pump Inhibitors
  • Analgesics
  • Antacids
  • Voice Therapy
  • Behavioural Counseling

          Age Group

  • Pediatrics
  • Adults
  • Elderly

          Distribution Channel

  • Hospitals
  • Clinics
  • Retail
  • Specialized Centers
  • Retail Pharmacies
  • Online Pharmacies

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Muscle Tension Dysphonia Treatment Industry - Regional Synopsis

North American Market Forecast

The North American muscle tension dysphonia treatment market is expected to hold the largest share of 37% during the forecast period. The condition is growing more widely recognized and understood, which is driving up demand for available treatment alternatives. Many medical specialists who treat muscular tension dysphonia specifically in North America include otolaryngologists and speech-language pathologists. These specialists specialize in voice abnormalities. According to a report in 2021, more than 17,837 speech therapists were working in the US. Women accounted for 91.0% of speech therapists, and men made up 9.0%. Furthermore, improvements in research and development have made it possible to implement more individualized and successful treatment plans. The need for skilled specialists and the increasing focus on vocal health are likely to fuel the growth of the muscle tension dysphonia treatment market in North America.

European Market Statistics

Europe muscle tension dysphonia treatment market is anticipated to grow gradually with a share of 28% during the forecast period. The region's increasing prevalence of chronic conditions like autism, brain tumors, and cerebral palsy is thought to be the reason for the market's rise. Additionally, muscular tension dysphonia has grown more easily diagnosed and treated, making it more accessible to people in Europe thanks to increased scientific and technological breakthroughs. One such development is the use of biofeedback devices, which enable people with muscular tension dysphonia to monitor and modify their vocal behaviors in real-time through visual or audio input. This can help to promote better vocal production and ease excessive strain.

Research Nester
Muscle Tension Dysphonia Treatment Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Muscle Tension Dysphonia Treatment Market

top-features-companies
    • Verboso LLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • SpeakSuite, Inc.
    • Pfizer Inc.
    • Cipla Inc.
    • Merck & Co., Inc.
    • Astellas Pharma Inc.

In-the-news

In The News

  • A new virtual speech treatment platform powered by speech recognition has been introduced by Verboso, a former recipient of the Microsoft AI for Accessibility grant. It takes an inventive approach to online speech therapy. In-person sessions with a professional and licensed speech-language pathologist are combined with unique games that each client's therapist tailors to their own needs to provide feedback for at-home practice. With the use of speech recognition software, these specifically created games for speech therapy facilitate the practice of the correct speech patterns that are taught during sessions.
  • SpeakSuite is raising the standard for speech-therapy support services as it enters its second year in the North American market. SpeakSuite is pleased to announce the introduction of its first significant platform update. The revolutionary platform was introduced in 2022 to enable speech therapy treatment. These innovations redesigned the user experience and set the stage for a time of significant expansion, coming after a rebrand and the appointment of a new CEO earlier this summer.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5631
  • Published Date: Feb 12, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing sponsored research and development activities by the government, growing demand for personalized diagnostic techniques, and increased stress among adults and children are the major factors driving the growth of the muscle tension dysphonia treatment market.

The market size of muscle tension dysphonia treatment is anticipated to attain a CAGR of 3% over the forecast period, i.e., 2024-2036.

The major players in the market are Verboso LLC, SpeakSuite, Inc., Pfizer Inc., Cipla Inc., Merck & Co., Inc., Astellas Pharma Inc., Daiichi Sankyo Co Ltd., Takeda Pharmaceutical Co Ltd., CoeFont Inc., Teijin Ltd., Otsuka Holdings Co Ltd., and others.

The adult segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Muscle Tension Dysphonia Treatment Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying